Time to Second-line Treatment and Subsequent Relative Survival in Older Patients With Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

We investigated whether stratifying by the interval between first-line (T1) and second-line (T2) treatments could identify a subgroup of older patients with relapsed CLL/SLL with an expectation of normal overall survival. Longer time-to-T2 was associated with a modestly improved prognosis; however,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Lymphoma Myeloma Leuk
Autors principals: Ammann, Eric M., Shanafelt, Tait D., Larson, Melissa C., Wright, Kara B., McDowell, Bradley D., Link, Brian K., Chrischilles, Elizabeth A.
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5769450/
https://ncbi.nlm.nih.gov/pubmed/28802891
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2017.07.004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars